Shengjiang Powder alleviates oxidative stress damage and fibrosis in mice with atherosclerosis concurrent with non-alcoholic fatty liver disease
Crossref DOI link: https://doi.org/10.1186/s41065-025-00598-y
Published Online: 2025-11-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
He, Jia
Lu, Bingjiu
Zhang, Yan
Sun, Jingran
Fu, Bo
Wang, Tianqing
Text and Data Mining valid from 2025-11-12
Version of Record valid from 2025-11-12
Article History
Received: 18 June 2025
Accepted: 8 October 2025
First Online: 12 November 2025
Declarations
:
: Not applicable.
: The authors declare no competing interests.